Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

IVUS guidance during DES implantation boosts long-term outcomes in new study

Performing TAVR and TMVR during the same hospitalization may provide value

Patients undergoing both procedures at once tended to be sicker, but their risk of poor outcomes did not significantly increase. 

January 24, 2022
With advances and increased experience in the percutaneous coronary intervention (PCI), same-day discharge (SDD) has become increasingly commonplace, but patient selection is key. Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis published in JACC: Cardiovascular Interventions.

Adjusting implantation technique during TAVR reduces risk of permanent pacemakers

Researchers emphasized that permanent pacemakers are “one of the most feared complications" associated with TAVR. 

January 21, 2022
With advances and increased experience in the percutaneous coronary intervention (PCI), same-day discharge (SDD) has become increasingly commonplace, but patient selection is key. Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis published in JACC: Cardiovascular Interventions.

Hydra THV associated with promising TAVR outcomes after 1 year

Researchers reported "significant improvements" in patients after one year. 

January 13, 2022
Doctor patient

LAAC or DOACs? How treatment strategies for AFib impact long-term outcomes

The new analysis provided an update on data from the PRAGUE-17 trial. 

January 11, 2022
approved approval safe

Self-expanding TAVR system gains approval for high-risk patients in China

The National Medical Products Administration reviewed data from more than 32,000 patients to make its decision.

January 10, 2022
overnight night shift attending radiologist burnout. A new policy statement from the American College of Cardiology highlights the importance of career flexibility—including the ability to change hours or work responsibilities when necessary—for cardiologists of all ages. 

Researchers take a fresh look at how different risk factors impact the look of a patient's heart

The study included cardiac MRI scans of nearly 30,000 patients. 

December 22, 2021
approved approval

Edwards gains FDA approval for new Sapien 3 solution for TPV replacement

The system was designed to treat both pediatric and adult patients.

December 20, 2021

AI improves detection of severe CAD in stress echocardiograms

Advanced algorithms can lead to significant improvements in agreement among specialists, researchers found. 

December 17, 2021

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup